drugset / Trial / NCT02038634

Ultrasound-guided Injection for DeQuervain's

NCT02038634

Phase 4 Terminated 16 enrolled Medical College of Wisconsin
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators aim to perform a prospective study to evaluate the effectiveness of blind corticosteroid injections to US-guided injections for the treatment of de Quervain's disease. The results of the study will be used to validate current injection protocols or support the incorporation of ultrasonography to treat the disease.

Timeline

Start
2014-08-05
Primary completion
2021-03-15
Completion
2021-03-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betamethasone Other / unclassified

Indications